NCT00230477View on ClinicalTrials.gov

Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

August 31, 2007

Conditions
Hepatitis B
Interventions
DRUG

Hepsera

DRUG

Hepsera and lamivudine

Trial Locations (1)

98104

Harborview Medical Center, Seattle

Sponsors
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Washington

OTHER